We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
(-11%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102
Avg Time Held Equity + Options
1.8
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.64M |
| 2 |
Lindsay Corp
LNN
|
+$2.12M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.77M |
| 4 |
Boston Scientific
BSX
|
+$1.51M |
| 5 |
Verizon
VZ
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.34M |
| 2 |
3D Systems Corp
DDD
|
+$1.86M |
| 3 |
Lennar Class A
LEN
|
+$989K |
| 4 |
BlackBerry
BB
|
+$938K |
| 5 |
Vince Holding Corp
VNCE
|
+$928K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.91% |
| 2 | Miscellaneous | 27.85% |
| 3 | Healthcare | 13.47% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Burlington
BURL
$16.9B
| $443K | 0.24% |
15,000
-10,000
| -40% | -$275K |
2013 Q4
1 quarter
|
|
102
Incyte
INCY
$22.6B
| $428K | 0.23% |
8,000
-2,500
| -24% | -$155K |
2013 Q4
1 quarter
|
|
103
CALL
DELISTED
Primo Water Corporation
PRMW
| $424K | 0.23% |
+50,000
| New | +$403K |
2014 Q1
0 quarters
|
|
|
FIO
104
DELISTED
FUSION-IO INC COM
FIO
| $421K | 0.23% |
+40,000
| New | +$423K |
2014 Q1
0 quarters
|
|
105
Marchex
MCHX
$57.2M
| $420K | 0.23% |
+40,000
| New | +$423K |
2014 Q1
0 quarters
|
|
|
OTE
106
DELISTED
HELLENIC TELECOMM ORG ADS(RP1/
OTE
| $414K | 0.22% |
50,000
| – | – |
2013 Q2
3 quarters
|
|
107
Grifois
GRFS
$5.02B
| $413K | 0.22% |
20,000
+5,714
| +40% | +$114K |
2013 Q2
3 quarters
|
|
108
DELISTED
Bazaarvoice, Inc.
BV
| $402K | 0.22% |
+55,000
| New | +$416K |
2014 Q1
0 quarters
|
|
|
ACAS
109
DELISTED
American Capital Ltd
ACAS
| $395K | 0.21% |
+25,000
| New | +$385K |
2014 Q1
0 quarters
|
|
110
DELISTED
PotlatchDeltic
PCH
| $387K | 0.21% |
10,000
| – | – |
2013 Q2
3 quarters
|
|
111
Novavax
NVAX
$2.06B
| $385K | 0.21% |
4,250
-750
| -15% | -$83.8K |
2013 Q4
1 quarter
|
|
112
RH
RH
$2.21B
| $368K | 0.2% |
5,000
-7,500
| -60% | -$468K |
2013 Q2
3 quarters
|
|
113
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $364K | 0.2% |
+20,030
| New | +$362K |
2014 Q1
0 quarters
|
|
|
AVHI
114
DELISTED
A V Homes, Inc.
AVHI
| $362K | 0.2% |
20,000
| – | – |
2013 Q2
3 quarters
|
|
|
JMP
115
DELISTED
JMP Group LLC
JMP
| $356K | 0.19% |
50,000
| – | – |
2013 Q2
3 quarters
|
|
|
CVA
116
CALL
DELISTED
Covanta Holding Corporation
CVA
| $350K | 0.19% |
+19,400
| New | +$343K |
2014 Q1
0 quarters
|
|
117
DELISTED
Du Pont De Nemours E I
DD
| $349K | 0.19% |
+5,476
| New | +$335K |
2014 Q1
0 quarters
|
|
118
Heron Therapeutics
HRTX
$79.3M
| $348K | 0.19% |
25,000
| – | – |
2013 Q2
3 quarters
|
|
119
Peraso
PRSO
$5.77M
| $341K | 0.18% |
9
| – | – |
2013 Q2
3 quarters
|
|
120
Jefferies Financial Group
JEF
$10.3B
| $340K | 0.18% |
13,573
| – | – |
2013 Q2
3 quarters
|
|
|
CTIC
121
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $340K | 0.18% |
10,000
+5,000
| +100% | +$171K |
2013 Q2
3 quarters
|
|
122
Teekay Tankers
TNK
$3.74B
| $336K | 0.18% |
+11,875
| New | +$372K |
2014 Q1
0 quarters
|
|
|
CSOD
123
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $335K | 0.18% |
+7,000
| New | +$391K |
2014 Q1
0 quarters
|
|
124
Estee Lauder
EL
$36.2B
| $334K | 0.18% |
+5,000
| New | +$347K |
2014 Q1
0 quarters
|
|
|
ADEP
125
DELISTED
Adept Technology Inc
ADEP
| $333K | 0.18% |
+17,500
| New | +$301K |
2014 Q1
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2014 Portfolio in Review
As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
- E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
- E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
- E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
- E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
- E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
- E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.
Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.